IQ OPS is the codified blueprint of a complete practice intelligence system — 52 technical specifications, 158+ operational playbooks across 12 intelligence domains, validated across 12 practices in dental and medical verticals. Available for strategic acquisition.
A strategic acquirer is buying the documented IP that lets their existing engineering team deploy operational intelligence across a practice portfolio. No vendor dependency, no licensing arrangement, no ongoing operational handoff required.
Every existing platform in this category reports what happened. IQ OPS tells specific people what to do, when to do it, and how. That distinction is the moat.
Dental Intelligence, Jarvis Analytics, Practice by Numbers, Pearl AI, and the major PMS vendors all do roughly the same thing — they aggregate practice data into dashboards, charts, and reports for practice owners. The owner reads the report. The team is expected to figure out what to do about it.
IQ OPS does something fundamentally different. It identifies specific missing revenue opportunities, then assigns specific tasks to specific staff members with step-by-step playbooks, scripts, and timing. The billing coordinator receives a list of underpayments to dispute. The treatment coordinator receives a list of unaccepted cases to follow up on. The scheduling coordinator receives chair gaps to fill with named patients from a standby list.
This validated at a Heartland webinar in 2025, where an executive confirmed that no existing platform in the market identifies missing revenue via AI and delegates remediation tasks to specific team members. The operational gap is real, and the difference compounds across a practice portfolio.
Every operational software buyer asks the same question: can you prove your platform is the cause of the result, not a coincidence? IQ OPS has the answer documented at one pilot site.
Practice B is the validation site specifically designed to settle the correlation-versus-causation question. From February 2024 through July 2025, IQ OPS was active and produced documented monthly improvements. In August 2025, IQ OPS was deliberately withdrawn — all dashboards, all task assignments, all playbook references, all SQL triggers, withdrawn for one full month. No staff were terminated. No providers left. No fee schedule changes. No payer terminations.
Production dropped from $33,400 in July to $14,000 in August — a 58% decline. Insurance denial recovery dropped to zero. Patient AR escalation dropped to zero. Chair gap recovery dropped to zero. Case acceptance follow-up dropped from 78% to 42%. The 58% drop matched almost exactly what the IQ OPS attribution model had predicted in advance.
IQ OPS was reactivated on September 1. Production recovered within 21 days. By November 2025, the practice was producing at the highest monthly output in its history. This is the strongest single piece of evidence in the dataset, and it directly answers the most common buyer concern about operational software.
The pilot data shows three distinct deployment scenarios — depending on the practice's starting condition. A sophisticated acquirer running this math across a portfolio of hundreds or thousands of practices arrives at a substantial EBITDA opportunity.
Qualified buyers receive access to an interactive demonstration of the IQ OPS platform — a portfolio dashboard with four featured practices, each showing the operational view, monthly performance recap, and yearly performance recap. The Practice B causality experiment is documented within the platform itself.
Strategic buyers can reach the founder directly for product, vision, validation data, and deal-level discussion. The path leads to the full data room under mutual NDA.
Complete the form below to request demo access. Nancy will personally review your request and send a mutual NDA for e-signature within one business day. Demo access follows signature.